Corcept Therapeutics Director James N. Wilson Transfers Shares to Family Trusts

James N. Wilson, a director of Corcept Therapeutics Inc., filed a Form 4 disclosing significant share transfers on May 27, 2026. Wilson transferred 892,056 shares from James and Pamela Wilson Family Partners, reducing that holding to 9,011 shares, then transferred those remaining 9,011 shares to the James N. Wilson and Pamela D. Wilson Trust. The trust subsequently received an additional 9,011 shares, bringing its total holdings to 1,104,543 shares. All transactions were coded as "G" gifts with $0.00 consideration. Wilson also maintains indirect ownership of 200,000 shares each through the James N. Wilson 2025 Grantor Retained Annuity Trust and Pamela D. Wilson 2025 Grantor Retained Annuity Trust. The filing notes Wilson has voting power over trust shares but disclaims beneficial ownership except for his pecuniary interest.